PEDIATRIX ORAL SOLUTION 100mg: Out of specification
Brand(s)
Last updated
Summary
Product
PEDIATRIX
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Distribution
Ontario
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|---|---|---|---|---|
| PEDIATRIX | PEDIATRIX ORAL SOLUTION | DIN 02027798 | Solution | ACETAMINOPHEN, 160mg/5ml | MC0079 |
Issue
The assay is out of specification for the affected lot.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesalers, Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Teva Canada Limited
30 Novopharm Court
Toronto, Ontario
M1B 2K9
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
Ontario
Recall class
Type II
Identification number
RA-74912
Get notified
Receive emails about new and updated recall and safety alerts.